ANGO AngioDynamics Corp: רווח למניה ב-12 החודשים האחרונים

This EPS (TTM) price chart for AngioDynamics, Inc. (ANGO) shows a figure of -0.80. AngioDynamics, Inc. (ANGO) develops minimally invasive equipment for vascular procedures, targeting clinics and radiology centers. The business faces intense pressure from corporate behemoths and agile innovators. Production efficiency is increasing through the implementation of AI-driven robotic assembly lines.

This metric reflects net income sensitivity to operating expenses under tight monetary policy. This indicator measures the rate of capital accumulation over the last twelve months, revealing hidden business stagnation. For AngioDynamics, Inc. (ANGO), this calculation depends directly on the efficiency of government procurement and insurance reimbursement terms for medical technology. By analyzing the 12-month YoY EPS growth rates, an investor can forecast a potential correction of market multiples.